1-4 of 4
Pierre Sie
Close
Sort by
Journal Articles

Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions

Brief Report
Marie Levade, Elodie David, Cédric Garcia, Pierre-Alexandre Laurent, Sarah Cadot, Anne-Sophie Michallet, Jean-Claude Bordet, Constantine Tam, Pierre Sié, Loïc Ysebaert, Bernard Payrastre
Journal: Blood
Blood (2014) 124 (26): 3991–3995.
https://doi.org/10.1182/blood-2014-06-583294
Published: 2014
Includes: Multimedia, Supplemental data
Journal Articles

Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α

Marie-Cécile Valéra, Marie-Pierre Gratacap, Pierre Gourdy, Françoise Lenfant, Cendrine Cabou, Celine E. Toutain, Marlene Marcellin, Nathalie Saint Laurent, Pierre Sié, Michel Sixou, Jean-François Arnal, Bernard Payrastre
Journal: Blood
Blood (2012) 120 (8): 1703–1712.
https://doi.org/10.1182/blood-2012-01-405498
Published: 2012
Journal Articles

The new tyrosine-kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo

Marie-Pierre Gratacap, Valérie Martin, Marie-Cécile Valéra, Sophie Allart, Cédric Garcia, Pierre Sié, Christian Recher, Bernard Payrastre
Journal: Blood
Blood (2009) 114 (9): 1884–1892.
https://doi.org/10.1182/blood-2009-02-205328
Published: 2009
Includes: Supplemental data
Journal Articles

Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men

Brief Report
Yves Cadroy, Kjell S. Sakariassen, Jean-Paul Charlet, Claire Thalamas, Bernard Boneu, Pierre Sie
Journal: Blood
Blood (2001) 98 (10): 3159–3161.
https://doi.org/10.1182/blood.V98.10.3159
Published: 2001